Neuropathy & Pain Relief Therapy

NeuroMed Electroanalgesia Therapy (Matrix System) NeuroMed’s Electroanalgesia Therapy is a drug-free, non-surgical treatment for neuropathy pain that goes far beyond traditional TENS. Using high-frequency stimulation up to 10,000 pulses per second, it not only disrupts pain signals but also promotes nerve healing, circulation, and reduced inflammation. Treatments are quick, safe, reimbursable, and easily integrated into clinic workflows, giving patients lasting relief and providers a reliable in-house therapy option.

This Advanced Medical Technology Has Been Reimbursed by

Medicare, Medicaid, Private Insurance and Workers Compensation Nationally

Neuropathy Pain Relief

The NeuroMed Matrix System delivers Electroanalgesia Therapy, one of the most advanced, non-invasive, and drug-free treatments available for chronic neuropathy pain. Unlike traditional TENS units that provide only surface-level symptom relief, the Matrix System uses patented high-frequency technology that delivers up to 10,000 pulses per second. These frequencies go deeper, disrupting abnormal pain signals while also stimulating nerve pathways, improving local circulation, reducing inflammation, and encouraging long-term nerve healing.

Clinical Evidence and Studies
The effectiveness of Electroanalgesia Therapy is supported by peer-reviewed clinical studies and over two decades of research, showing meaningful reductions in neuropathic pain severity and improvements in patient quality of life. Patients who previously depended on medications or invasive procedures often experience relief, greater mobility, and improved sleep after a consistent course of treatments. By addressing the underlying nerve dysfunction rather than masking symptoms, the Matrix System provides a pathway toward durable pain relief and functional improvement.

Simplicity for Clinics

The Matrix System was designed with providers in mind. Each therapy session lasts only 20–25 minutes, can be administered by trained staff, and follows pre-programmed treatment protocols tailored to neuropathy and related pain syndromes. The device is compact, requires no special construction or facility changes, and integrates easily into both primary care and specialty clinic workflows. With turnkey support from DTC’s Chronic Care Programs®, providers receive full guidance on clinical protocols, workflow integration, and compliant billing.

Why Clinics Should Offer This Therapy
Peripheral neuropathy affects millions of Americans, especially patients with diabetes, and is a leading driver of pain, disability, and preventable amputations. Yet too often, providers lack non-invasive, effective solutions to offer patients who have exhausted medications or are unsuitable for long-term drug therapy. The NeuroMed Matrix System fills that gap, enabling clinics to deliver evidence-based pain relief while also qualifying for Medicare and commercial reimbursement under established therapy codes.

By offering the Matrix System, providers can:

Expand care options for high-risk diabetic and neuropathy patients.
Deliver drug-free, non-surgical pain relief backed by research.
Preserve patient independence, mobility, and quality of life.
Capture new, sustainable revenue streams through reimbursable therapy.
Keep patients in-house instead of sending them to outside pain specialists.

The DTC Advantage
Through Diabetes Testing Centers™ (DTC), the NeuroMed Matrix System is integrated into a larger Diabetic Neuropathy + Pain Relief & Balance Program, combining advanced neuropathy testing, Electroanalgesia Therapy, and biofeedback balance training. This comprehensive model equips providers not only to detect neuropathy earlier, but also to treat pain, reduce fall risk, and prevent amputations—all with turnkey support and reimbursement guidance.

With the Matrix System, providers don’t just treat symptoms. They protect patients from losing mobility, independence, and quality of life, while strengthening their practice with proven, reimbursable therapy.

Simply Better

Page updated

Report abuse